Condensed Consolidated Statements of Earnings - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|||||||||||||
| Income Statement [Abstract] | ||||||||||||||||
| Net revenues (Note 13) | $ 11,192 | [1],[2] | $ 10,140 | [1],[2] | $ 21,338 | [3],[4] | $ 19,441 | [3],[4] | ||||||||
| Cost of sales (Note 1) | 3,533 | 3,274 | 6,774 | 6,305 | ||||||||||||
| Gross profit | 7,659 | 6,866 | 14,564 | 13,136 | ||||||||||||
| Marketing, administration and research costs (Notes 1 & 15) | 2,981 | 2,988 | 5,838 | 5,416 | ||||||||||||
| Impairment of goodwill (Note 5) | 0 | 41 | 0 | 41 | ||||||||||||
| Corporate expenses and other (Note 1) | 148 | 125 | 303 | 423 | ||||||||||||
| Operating income | 4,530 | 3,712 | 8,423 | 7,256 | ||||||||||||
| Interest expense, net | 243 | 277 | 480 | 518 | ||||||||||||
| Pension and other employee benefit (income) costs (Note 4) | (5) | 11 | (10) | 23 | ||||||||||||
| Earnings before income taxes | 4,292 | 3,424 | 7,953 | 6,715 | ||||||||||||
| Provision for income taxes | 955 | 652 | 1,631 | 1,311 | ||||||||||||
| Impairment related to the RBH equity investment (Note 13) | 511 | 0 | 511 | 0 | ||||||||||||
| Equity investments and securities (income)/loss, net (Note 13) | (159) | (376) | 244 | (581) | ||||||||||||
| Net earnings | 2,985 | 3,148 | 5,567 | 5,985 | ||||||||||||
| Net earnings attributable to noncontrolling interests | 168 | 109 | 312 | 256 | ||||||||||||
| Net earnings attributable to PMI | $ 2,817 | $ 3,039 | $ 5,255 | $ 5,729 | ||||||||||||
| Per share data (Note 7): | ||||||||||||||||
| Basic earnings per share (in dollars per share) | $ 1.80 | $ 1.95 | $ 3.36 | $ 3.67 | ||||||||||||
| Diluted earnings per share (in dollars per share) | $ 1.80 | $ 1.95 | $ 3.36 | $ 3.67 | ||||||||||||
| ||||||||||||||||
| X | ||||||||||
- Definition Corporate expenses represent costs incurred by the company’s central governing unit to support strategic direction, target setting, compliance, governance, and global management activities. Other includes foreign currency gains/losses and compensation expense related to restricted share units and performance share units awards. No definition available.
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as research and development costs and all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. Research and development costs represent the aggregate costs incurred during an accounting period to research and develop new products/technologies. General and administrative expenses include costs such as salaries of nonsales personnel, rent, utilities and communication. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of impairment loss on investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as nonoperating. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|